Acquisitions (Tables)

9 Months Ended

Jun. 28, 2013

Business Combinations [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following amounts represent the final allocation of the fair value of the identifiable assets acquired and liabilities assumed:

Current assets (1)	$	13.3
Intangible assets	91.9
Goodwill (non-tax deductible) (2)	24.5
Total assets acquired	129.7
Current liabilities	4.0
Deferred tax liabilities (non-current)	27.1
Contingent consideration (non-current)	6.9
Total liabilities assumed	38.0
Net assets acquired	$	91.7

(1) This amount includes $3.3 million of accounts receivable, which is also the gross contractual value. As of the acquisition date, the fair value of accounts receivable approximated carrying value.

(2) Goodwill relates to the Company's ability to exploit CNS Therapeutics' technologies.

Schedule of Reconciliation of Total Consideration

The following reconciles the total consideration to net assets acquired:

Total consideration	$	95.0
Plus cash assumed in acquisition	3.6
Less: contingent consideration	(6.9		)
Net assets acquired	$	91.7

Schedule of Intangible Assets Acquired as Part of Business Combination

Intangible assets acquired consist of the following:  

	Amount		Weighted-Average Amortization Period
Completed technology	$	73.1	13 years
Trademark	0.2		3 years
In-process research and development	18.6		Non-Amortizable
	$	91.9